FBIO - Fortress Biotech - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

31.48M

Cash

152.5M

Avg Qtr Burn

-43.94M

Short % of Float

0.70%

Insider Ownership

31.08%

Institutional Own.

24.70%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
CUTX-101 (Copper Histidinate) Details Menkes Disease , Blood cancer	NDA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CAEL-101 Details Amyloid light chain amyloidosis	Phase 3 Interim Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Triplex Details Cytomegalovirus	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CEVA-101 Details Traumatic brain injury	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.